Study of efficacy of romiplostim for unreactive condition in platelet transfusion after cord blood transplantation

Study of efficacy of romiplostim for unreactive condition in platelet transfusion after cord blood transplantation - Cord blood transplantation and romiplostim

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009276

Enrollment

Registered

2012-11-07

Start date

2013-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cord blood transplantation

Interventions

treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CBT

Exclusion criteria

Exclusion criteria: severe infection

Design outcomes

Primary

Measure	Time frame
efficacy of romiplostim	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026